Screener
Ginkgo Bioworks DNA EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's EBITDA?
- Ginkgo Bioworks (DNA) reported EBITDA of -$46.23M in Q2 2026.
- How has Ginkgo Bioworks's EBITDA changed year-over-year?
- Ginkgo Bioworks's EBITDA decreased by 7.7% year-over-year, from -$42.91M to -$46.23M.
- What is the long-term trend for Ginkgo Bioworks's EBITDA?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's EBITDA has grown at a -39.5% compound annual growth rate (CAGR), from -$1.8B to -$240.91M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Ginkgo Bioworks's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude